Medical robotics

Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities

Retrieved on: 
Tuesday, April 13, 2021
Life sciences, Prosthetics, Robotics, Technology, Ekso Bionics, Biotechnology, Biological engineering, Medical robotics, Bionics, Powered exoskeleton, Artificial organ, Edwards Lifesciences

This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high.

Key Points: 
  • This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high.
  • Bionics and artificial organs are able to cater to the needs of those in need of organ transplantations and replacements.
  • In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.\n2.
  • In April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring.\n3.

Global Artificial Organ and Bionics Market (2020 to 2025) - by Type, Technology, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 8, 2021
Health, Biotechnology, Life sciences, Robotics, Articles, Ekso Bionics, Medical robotics, Powered exoskeleton, Kindred Healthcare, Edwards Lifesciences, Bionics

In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.

Key Points: 
  • In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.
  • In April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring.
  • The report offers a comprehensive evaluation of the Global Artificial Organ and Bionics Market.
  • The report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool.

ReWalk Robotics to Present at the H.C. WAINWRIGHT Global Life Sciences Virtual Conference

Retrieved on: 
Thursday, March 4, 2021
Robotics, Assistive technology, Technology, Science and technology, ReWalk, Medical robotics, Powered exoskeleton, Yokneam

and BERLIN and YOKNEAM ILIT, Israel, March 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT global life science conference held on March 9 10, 2021.

Key Points: 
  • and BERLIN and YOKNEAM ILIT, Israel, March 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT global life science conference held on March 9 10, 2021.
  • A company presentation will be available to view on-demand as of 7:00 AM EST, Tuesday, March 9, 2021 and throughout the conference in the following link https://journey.ct.events/view/6a0c05fb-238a-4665-8be3-13f91fdab5a4 .
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.

Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology

Retrieved on: 
Wednesday, March 3, 2021
Ekso Bionics, Peripheral Component Interconnect, Technology, Computing, Science and technology, Assistive technology, Medical robotics

Over the course of a year, PCI employees in six Bay Area counties have committed to testing EVO exoskeleton vests for the Companys continued product development and innovation.

Key Points: 
  • Over the course of a year, PCI employees in six Bay Area counties have committed to testing EVO exoskeleton vests for the Companys continued product development and innovation.
  • We are excited that PCIs workforce will benefit from our novel EVO technology, commented Michael Pratt, Vice President of Ekso Bionics.
  • Companies within the construction vertical are starting to recognize that EVO provides meaningful support for workers when performing routine and labor-intensive tasks.
  • To learn more about Ekso Bionics please visit the Companys website at www.eksobionics.com or follow @EksoBionics on Twitter.

Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference

Retrieved on: 
Tuesday, March 2, 2021
Ekso Bionics, Life sciences, Health sciences, Articles, Assistive technology, Medical robotics

RICHMOND, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright Global Life Sciences Conference held on March 9 10, 2021.

Key Points: 
  • RICHMOND, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright Global Life Sciences Conference held on March 9 10, 2021.
  • Ekso Bionicsis a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.
  • The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

Sarcos Robotics Named 2021 Product Innovation Award Winner by IEEE Robotics and Automation Society for the Guardian XO Exoskeleton

Retrieved on: 
Monday, March 1, 2021
Technology, Hardware, Other Technology, Robotics, Medical robotics, Raytheon Company, Sarcos, Science and technology, Technology, IEEE Robotics and Automation Society, Powered exoskeleton, Robot, Stephen Jacobsen, Domenico Prattichizzo

View the full release here: https://www.businesswire.com/news/home/20210301005177/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210301005177/en/
    Sarcos Robotics Named 2021 Product Innovation Award Winner by IEEE Robotics and Automation Society for the Guardian XO Exoskeleton (Photo: Business Wire)
    The annual RAS Product Innovation Award was established in 2010 to identify companies that have made innovative commercial products using Robotics and Automation Science and Technology.
  • The Guardian XO robot was chosen for its role in moving the robotics and automation industry forward in full-body, powered exoskeleton technology and for the potential impact in reducing workplace injuries while simultaneously increasing worker productivity.
  • We are incredibly proud to be recognized once again by the IEEE Robotics and Automation Society for our efforts in the development of innovative robotic technologies, and particularly for our Guardian XO full-body, powered exoskeleton, said Ben Wolff, chairman and CEO, Sarcos Robotics.
  • The Guardian XO exoskeleton has been in development for multiple decades, so this award validates all of the hard work our team has dedicated to this project.

ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market

Retrieved on: 
Friday, February 26, 2021
Assistive technology, Robotics, Technology, Articles, Medical robotics, ReWalk, Prosthetics, Powered exoskeleton, Trademark

H.C. Wainwright & Co., LLC acted as the sole placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co., LLC acted as the sole placement agent for the offering.
  • ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStoreis a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.

Innophys to Begin Marketing "MUSCLE SUIT Every" in Europe on Acquisition of CE Certification Showing It Meets Local Safety Standards

Retrieved on: 
Thursday, February 25, 2021
Robotics, Medical robotics, Prosthetics, Technology, Powered exoskeleton, Science and technology, Exoskeleton

TOKYO, Feb. 25, 2021 /PRNewswire/ -- Tokyo-based Innophys Co., Ltd. (hereinafter "Innophys") is set to begin marketing "MUSCLE SUIT Every," a work-assisting robotic suit it has developed and sells, in European Union (EU) member countries in 2021 as the powered exoskeleton obtained CE certification on Dec. 10, 2020, showing it meets safety standards in Europe.

Key Points: 
  • TOKYO, Feb. 25, 2021 /PRNewswire/ -- Tokyo-based Innophys Co., Ltd. (hereinafter "Innophys") is set to begin marketing "MUSCLE SUIT Every," a work-assisting robotic suit it has developed and sells, in European Union (EU) member countries in 2021 as the powered exoskeleton obtained CE certification on Dec. 10, 2020, showing it meets safety standards in Europe.
  • The official global website on MUSCLE SUIT Every provides information relating to the product in English, French, German, Spanish, Italian, Swedish, Finnish, Polish and Dutch as of February 2021.
  • The powered exoskeleton, which weighs only 3.8 kilograms, provides up to 25.5kgf of assistive force to its user.
  • By the end of December 2020, the number of the product sold had surpassed 16,000 units.

Opportunities of Robotics in Enterprise Industry, 2020 Report Featuring German Bionic Systems, Locus Robotics, Sarcos, Universal Robots, & Vecna Robotics

Retrieved on: 
Monday, February 22, 2021
Articles, Science and technology, Medical robotics, Industrial robotics, Robotics, Cobot, Robot, Innovation, Powered exoskeleton

DUBLIN, Feb. 22, 2021 /PRNewswire/ -- The "Opportunities of Robotics in Enterprise Industry" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 22, 2021 /PRNewswire/ -- The "Opportunities of Robotics in Enterprise Industry" report has been added to ResearchAndMarkets.com's offering.
  • The Growth Opportunity report on Opportunities of Robotics in Enterprise Industry discusses the impact of Collaborative Robots, Material Handling Robots and Robotic Exoskeletons in the Enterprise Industry.
  • Robotics technology has been undergoing major technological growth in recent years.
  • 7.1 Growth Opportunity 1: R&D Investment for Technological Innovation, 2020 - Cobots
    7.2 Growth Opportunity 2: R&D Investment for Technological Innovation, 2020 - Material Handling & Warehouse Robot
    7.3 Growth Opportunity 3: R&D Investment for Technological Innovation, 2020 - Robotic Exoskeleton

ReWalk Robotics Announces $40.0 Million Private Placement Priced At-the-Market

Retrieved on: 
Friday, February 19, 2021
Assistive technology, Technology, Articles, Medical robotics, ReWalk, Powered exoskeleton, Trademark, Robotics, Ekso Bionics

The closing of the private placement is expected to occur on or about February 23, 2021, subject to satisfaction of customary closing conditions.

Key Points: 
  • The closing of the private placement is expected to occur on or about February 23, 2021, subject to satisfaction of customary closing conditions.
  • ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStoreis a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.